文献速递甲状腺疾病

由截短型PAX8突变导致的先天性甲状腺功能减退症:病例系列及分子功能研究

Congenital Hypothyroidism Due to Truncating PAX8 Mutations: A Case Series and Molecular Function Studies.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本文报告3例经新生儿筛查诊断的先天性甲状腺功能减退症先证者,均携带位于配对域之外的截短型PAX8突变(I160Sfs*52、Q213Efs*27、F342Rfs*85),并存在甲状腺发育不良、接受左甲状腺素治疗。通过蛋白质印迹、细胞内定位和反式激活实验验证突变功能,发现I160fs-PAX8蛋白不稳定,Q213fs-PAX8和F342fs-PAX8蛋白表达及核定位正常但反式激活缺失,且Q213fs-PAX8与NKX2-1相互作用缺陷;重组蛋白实验提示PAX8第363-400氨基酸残基对PAX8-NKX2-1相互作用至关重要。

要点

  • 3例先证者均携带配对域之外的截短型PAX8突变,表现为甲状腺发育不良并接受左甲状腺素治疗。
  • Q213fs-PAX8和F342fs-PAX8蛋白表达及核定位正常,但反式激活功能丧失。
  • PAX8第363-400氨基酸残基(外显子10对应序列)对PAX8-NKX2-1相互作用至关重要。

核心结论

  • 报告了3个位于配对域之外的截短型PAX8突变的临床与分子特征。
  • 培养细胞和重组蛋白实验表明PAX8的C端部分(即363-400氨基酸残基)为PAX8-NKX2-1相互作用所必需。

研究设计与样本

  • 病例系列研究,纳入3例经新生儿筛查诊断的先天性甲状腺功能减退症先证者。
  • 采用下一代测序进行突变筛查,并用蛋白质印迹、细胞内定位实验和反式激活实验(HeLa细胞)验证突变功能。
  • 采用荧光素酶互补实验评估突变对PAX8与其伙伴NKX2-1相互作用的影响,并对重组PAX8蛋白进行表征。

主要发现

  • 3例先证者分别携带I160Sfs*52、Q213Efs*27和F342Rfs*85截短型PAX8突变。
  • 蛋白质印迹显示I160fs-PAX8蛋白不稳定。
  • Q213fs-PAX8和F342fs-PAX8蛋白表达水平及核定位正常,但荧光素酶报告基因反式激活丧失。
  • 荧光素酶互补实验显示Q213fs-PAX8与NKX2-1相互作用存在缺陷。
  • 重组PAX8蛋白实验发现对应外显子10的蛋白序列(363-400氨基酸残基)对PAX8-NKX2-1相互作用至关重要。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: PAX8 is a transcription factor required for thyroid development, and its mutation causes congenital hypothyroidism (CH). More than 20 experimentally verified loss-of-function PAX8 mutations have been described, and all but one were located in the DNA-binding paired domain. OBJECTIVE: We report the identification and functional characterization of 3 novel truncating PAX8 mutations located outside the paired domain. METHODS: Three CH probands, diagnosed in the frame of newborn screening, had thyroid hypoplasia and were treated with levothyroxine. Next-generation sequencing-based mutation screening was performed. Functionality of the identified mutations were verified with Western blotting, intracellular localization assays, and transactivation assays with use of HeLa cells. Luciferase complementation assays were used to evaluate the effect of mutations on the interaction between PAX8 and its partner, NKX2-1. RESULTS: Each proband had novel truncating PAX8 mutations that were I160Sfs*52, Q213Efs*27, and F342Rfs*85. Western blotting showed destabilization of the I160fs-PAX8 protein. Q213fs-PAX8 and F342fs-PAX8 showed normal protein expression levels and normal nuclear localization, but showed loss of transactivation of the luciferase reporter. By luciferase complementation assays, we showed that PAX8-NKX2-1 interaction was defective in Q213fs-PAX8. We also characterized the recombinant PAX8 proteins, and found that the protein sequence corresponding to exon 10 (363-400 aa residues) was essential for the PAX8-NKX2-1 interaction. CONCLUSIONS: Clinical and molecular findings of 3 novel truncating PAX8 mutations located outside the paired domain were reported. Experiments using cultured cells and recombinant proteins showed that the C-terminal portion (ie, 363-400 aa) of PAX8 is required for the PAX8-NKX2-1 interaction.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Iwahashi-Odano M, Nagasaki K, Fukami M, et al. Congenital Hypothyroidism Due to Truncating PAX8 Mutations: A Case Series and Molecular Function Studies. J Clin Endocrinol Metab. 2020. PMID: 32841355. doi:10.1210/clinem/dgaa584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。